Neurogen Corporation Announces Third Quarter 2008 Financial Results and Updates Operations

BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (Nasdaq: NRGN), a drug development company focused on improved drugs for psychiatric and neurological disorders, today announced financial and operational results for the three and nine month periods ended September 30, 2008.

Back to news